{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:46:18Z","timestamp":1762641978687,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T00:00:00Z","timestamp":1500508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.bbi.2017.07.009","type":"journal-article","created":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T12:31:16Z","timestamp":1500294676000},"page":"89-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Associations of C-reactive protein and psychological distress are modified by antidepressants, supporting an inflammatory depression subtype: Findings from UKHLS"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5896-7650","authenticated-orcid":false,"given":"Amanda","family":"Hughes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meena","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bbi.2017.07.009_b0005","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/gps.4250","article-title":"The longitudinal associations between C-reactive protein and depressive symptoms: evidence from the English Longitudinal Study of Ageing (ELSA)","volume":"30","author":"Au","year":"2015","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2017.07.009_b0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/npp.2016.169","article-title":"Genetic contributions of inflammation to depression","volume":"42","author":"Barnes","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.bbi.2017.07.009_b0015","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.biopsych.2009.11.004","article-title":"The interleukin 1 beta (IL 1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression","volume":"67","author":"Baune","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2017.07.009_b0020","unstructured":"Benzeval, M., Davillas, A., et al., 2014. Understanding Society: The UK Household Longitudinal Study Biomarker User Guide and Glossary, Institute for Social and Economic Research, University of Essex."},{"key":"10.1016\/j.bbi.2017.07.009_b0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jad.2014.04.018","article-title":"Association of subsyndromal and depressive symptoms with inflammatory markers among different ethnic groups: the multi-ethnic study of atherosclerosis (MESA)","volume":"164","author":"Camacho","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2017.07.009_b0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jad.2014.03.023","article-title":"C-reactive protein, interleukin-6, soluble tumor necrosis factor alpha receptor 2 and incident clinical depression","volume":"163","author":"Chocano-Bedoya","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2017.07.009_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.socscimed.2016.10.001","article-title":"Psychosocial distress and inflammation: which way does causality flow?","volume":"170","author":"Das","year":"2016","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.bbi.2017.07.009_b0040","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jad.2016.10.046","article-title":"Lack of association between depression and C-reactive protein level in the baseline of Longitudinal Study of Adult Health (ELSA-Brasil)","volume":"208","author":"de Menezes","year":"2017","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.bbi.2017.07.009_b0045","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2017.07.009_b0050","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pnpbp.2007.09.015","article-title":"Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder","volume":"32","author":"Eller","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2017.07.009_b0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbi.2015.08.013","article-title":"Men and women differ in inflammatory and neuroendocrine responses to endotoxin but not in the severity of sickness symptoms","volume":"52","author":"Engler","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.bbi.2017.07.009_b0060","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1017\/S0033291708003723","article-title":"Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study","volume":"39","author":"Gimeno","year":"2009","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.bbi.2017.07.009_b0065","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1017\/S0033291796004242","article-title":"The validity of two versions of the GHQ in the WHO study of mental illness in general health care","volume":"27","author":"Goldberg","year":"1997","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.bbi.2017.07.009_b0070","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbi.2010.09.013","article-title":"Anti-depressant medication use and C-reactive protein: results from two population-based studies","volume":"25","author":"Hamer","year":"2011","journal-title":"Brain Behav. Immun."},{"issue":"9","key":"10.1016\/j.bbi.2017.07.009_b0075","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2017.07.009_b0080","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.bbi.2017.07.009_b0085","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.euroneuro.2012.09.009","article-title":"Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response","volume":"23","author":"Powell","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2017.07.009_b0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"10.1016\/j.bbi.2017.07.009_b0095","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006141","article-title":"Investigating the possible causal association of smoking with depression and anxiety using Mendelian randomisation meta-analysis: the CARTA consortium","volume":"4","author":"Taylor","year":"2014","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.bbi.2017.07.009_b0100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbi.2011.12.011","article-title":"A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia","volume":"26","author":"Tynan","year":"2012","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.bbi.2017.07.009_b0105","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jad.2013.06.004","article-title":"CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies","volume":"150","author":"Valkanova","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2017.07.009_b0110","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.8","article-title":"Association of depressive disorders, depression characteristics and antidepressant medication with inflammation","volume":"2","author":"Vogelzangs","year":"2012","journal-title":"Trans. Psychiatry"},{"key":"10.1016\/j.bbi.2017.07.009_b0115","article-title":"Association of inflammation with specific symptoms of depression in a general population of older people: the English Longitudinal Study of Ageing","author":"White","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"9","key":"10.1016\/j.bbi.2017.07.009_b0120","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00213-015-3919-9","article-title":"Low-grade inflammation predicts persistence of depressive symptoms","volume":"233","author":"Zalli","year":"2016","journal-title":"Psychopharmacology"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159117302167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159117302167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:46:33Z","timestamp":1760168793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159117302167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":24,"alternative-id":["S0889159117302167"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2017.07.009","relation":{},"ISSN":["0889-1591"],"issn-type":[{"type":"print","value":"0889-1591"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of C-reactive protein and psychological distress are modified by antidepressants, supporting an inflammatory depression subtype: Findings from UKHLS","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2017.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}